These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7332665)

  • 1. [Chromosome aberrations as morphological criteria of the effectiveness of chemotherapy of ovarian tumors].
    Irzhanov SI; Neĭshtadt EL; Aĭnbinder NM
    Akush Ginekol (Mosk); 1981 Sep; (9):22-4. PubMed ID: 7332665
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chromosome abnormalities in an ovarian cancer].
    Berger R; Lacour J
    Pathol Biol (Paris); 1974 Sep; 22(7):603-6. PubMed ID: 4612464
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of a human ovarian carcinoma cell line: UCI 101.
    Fuchtner C; Emma DA; Manetta A; Gamboa G; Bernstein R; Liao SY
    Gynecol Oncol; 1993 Feb; 48(2):203-9. PubMed ID: 8428692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetics of a cell line derived from an ovarian papillary serous cystadenocarcinoma.
    Hill SM; Rodgers CS; Hultén MA; Wilson AP
    Cancer Genet Cytogenet; 1984 Aug; 12(4):321-7. PubMed ID: 6744227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chromosome anomalies in 2 cases of human ovarian cancer].
    de Blois MC; Boyer P; Bénard J; Riou G
    C R Acad Sci III; 1986; 302(3):81-6. PubMed ID: 3082479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prediction of the clinical response of ovarian cancer to chemotherapy using an in vitro anticancer drug sensitivity test].
    Li ZX
    Zhonghua Fu Chan Ke Za Zhi; 1988 Sep; 23(5):287-9, 318. PubMed ID: 3250811
    [No Abstract]   [Full Text] [Related]  

  • 7. [Selective intra-arterial administration of CDDP in a malignant ovarian tumor with peculiar ultrastructural findings].
    Tateyama I; Kamitani N; Tominaga T; Mori T
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1981-5. PubMed ID: 3382245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface cells of the ovary and pelvic peritoneum: a histochemical and ultrastructure comparison.
    Blaustein A; Lee H
    Gynecol Oncol; 1979 Aug; 8(1):34-43. PubMed ID: 572317
    [No Abstract]   [Full Text] [Related]  

  • 9. [Nursing of a patient with ovarian cancer undergoing postoperative chemotherapy].
    Taguchi A; Nakane N; Watanabe M; Matsumoto S; Nakamura M
    Kango Gijutsu; 1989 Mar; 35(4):400-3. PubMed ID: 2754874
    [No Abstract]   [Full Text] [Related]  

  • 10. Cystadenocarcinoma of the ovary in a 4-year-old: benign transformation during therapy.
    Hong SJ; Lurain JR; Tsukada Y; Piver MS; Humbert JR; Freeman AI
    Cancer; 1980 Apr; 45(8):2227-30. PubMed ID: 7370965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial chemotherapy followed by surgical cytoreduction for the treatment of stage III/IV epithelial ovarian cancer.
    Everett EN; French AE; Stone RL; Pastore LM; Jazaeri AA; Andersen WA; Taylor PT
    Am J Obstet Gynecol; 2006 Aug; 195(2):568-74; discussion 574-6. PubMed ID: 16890558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of various factors on the results of chemotherapy in patients with recurrent ovarian serous cystadenocarcinoma].
    Dzhilavian GA; Vinokurov VL
    Vopr Onkol; 1984; 30(3):16-21. PubMed ID: 6424327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Morphological characteristics of serous ovarian adenocarcinomas after chemotherapy].
    Serov SF; Irzhanov SI
    Vopr Onkol; 1980; 26(3):37-40. PubMed ID: 7368655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current status and future developments in chemotherapy of advanced epithelial ovarian cancers (author's transl)].
    Szepesi T
    Wien Klin Wochenschr; 1981 Apr; 93(8):251-5. PubMed ID: 6266166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of four new cell lines from patients with adenocarcinoma of the ovary.
    Woods LK; Morgan RT; Quinn LA; Moore GE; Semple TU; Stedman KE
    Cancer Res; 1979 Nov; 39(11):4449-59. PubMed ID: 498076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adjuvant treatment of cystadenocarcinoma].
    Héron JF
    Rev Prat; 1989 Nov; 39(26):2325-8. PubMed ID: 2595223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic observations on two ovarian carcinomas with double minutes, one with a 6q- marker chromosome.
    Bullerdiek J; Bartnitzke S; Kahrs E; Schloot W
    Cytobios; 1985; 42(165):15-24. PubMed ID: 3858061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A newly established cel line derived from human ovarian adenocarcinoma.
    Sekiguchi M; Sakakibara K; Suzuki T; Motoyama T; Fujii G
    Jpn J Exp Med; 1980 Aug; 50(4):283-92. PubMed ID: 7441907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of mono- and polychemotherapy in patients with advanced ovarian cancer].
    Khasanova DT; Kotova DG
    Vopr Onkol; 1984; 30(3):67-71. PubMed ID: 6369776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mucinous cystadenocarcinoma of the ovary with Leydig cell hyperplasia].
    Detre Z; Földes E; Lintner F; Megyesi K
    Morphol Igazsagugyi Orv Sz; 1987 Oct; 27(4):267-73. PubMed ID: 2825003
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.